+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
PGHL

Procter & Gamble Health Share Price

₹5,543.50 -52 (-0.93%)

17 Nov, 2026 9:30 AM (IST)

Procter & Gamble Health live price: ₹5,543.50. It opened at ₹5,601 vs previous close ₹5,596; intraday high/low: ₹5,624/₹5,530. The 50 & 200 DMA stand at ₹5,572.70/₹5,679.60.

Procter & Gamble Health Performance

  • Today's Low
  • ₹5,530
  • Today's High
  • ₹5,624
  • 52 Week Low
  • ₹4,707
  • 52 Week High
  • ₹6,975
  • Open Price₹5,601
  • Previous Close₹5,596
  • Volume661
  • 50 DMA₹5,572.70
  • 100 DMA₹5,653.60
  • 200 DMA₹5,679.60

Procter & Gamble Health Chart

Investment Returns

  • Over 1 Month + 6.61%
  • Over 3 Month -6.55%
  • Over 6 Month + 4.59%
  • Over 1 Year -5.88%

Smart Investing Starts Here Start SIP with Procter & Gamble Health for Steady Growth!

Invest Now

Procter & Gamble Health Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.2
  • PEG Ratio
  • 1
  • Market Cap Cr
  • 9,202
  • P/B Ratio
  • 14.8
  • Average True Range
  • 202.1
  • EPS
  • 228.8
  • Dividend Yield
  • 3.7
  • MACD Signal
  • 95.7
  • RSI
  • 51.49
  • MFI
  • 72.15

Latest Stock News Updates

Procter & Gamble Health Ltd - 500126 - Intimation For Change In Corporate Office Address Of Registrar And Share Transfer Agent (RTA)

Intimation for Change in Corporate Office address of Registrar and Share Transfer Agent (RTA)

Q2FY27 Quarterly Result Announced for Procter & Gamble Health Ltd.

<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Procter & Gamble Health announced Q2FY27 results</strong></span></h3> <p><strong>Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAICBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="nr7Ngc_1c"> <li data-complete="true" data-hveid="CAAICBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="nr7Ngc_1d"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="nr7Ngc_1f">Total Income<!--TgQPHd|||[]--></strong>: Standalone Total Income reached Rs 38,638 lakh<!--TgQPHd|||[]--> in Q2FY27, showing an increase of 5.11% QoQ from Rs 36,759 lakh in Q1FY27 and registering a growth of 17.38% YoY compared to Rs 32,987 lakh in Q2FY26. For H1FY27, Standalone Total Income stood at Rs 75,397 lakh, up by 12.09% YoY from Rs 67,264 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="nr7Ngc_1d"><strong>Revenue from Operations<!--TgQPHd|||[]-->:</strong> Standalone Revenue from Operations stood at Rs 38,249 lakh<!--TgQPHd|||[]--> in Q2FY27, indicating a growth of 5.16% QoQ from Rs 36,371 lakh in Q1FY27 and up by 17.72% YoY against Rs 32,492 lakh in Q2FY26. For H1FY27, Revenue from Operations reached Rs 74,620 lakh, representing an increase of 12.44% YoY compared to Rs 66,366 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="nr7Ngc_1d"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="nr7Ngc_1x">Profit Before Tax (PBT)<!--TgQPHd|||[]--></strong>: Standalone PBT was Rs 15,005 lakh<!--TgQPHd|||[]--> in Q2FY27, representing a growth of 16.21% QoQ over Rs 12,912 lakh in Q1FY27 and an increase of 26.07% YoY from Rs 11,902 lakh in Q2FY26. For H1FY27, Standalone PBT reached Rs 27,917 lakh, a growth of 34.33% YoY against Rs 20,783 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="nr7Ngc_1d"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="nr7Ngc_26">Net Profit for the Period (PAT)<!--TgQPHd|||[]--></strong>: Standalone PAT was Rs 11,151 lakh<!--TgQPHd|||[]--> in Q2FY27, up 15.98% QoQ compared to Rs 9,615 lakh in Q1FY27 and recording a growth of 25.94% YoY against Rs 8,854 lakh in Q2FY26. For H1FY27, Standalone PAT reached Rs 20,766 lakh, a YoY expansion of 34.22% from Rs 15,472 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="nr7Ngc_1d"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="nr7Ngc_2f">Earnings Per Share (EPS) - </strong>Standalone Basic and Diluted EPS reached Rs 67.18<!--TgQPHd|||[]--> in Q2FY27, increasing by 73.28% QoQ against Rs 38.77 in Q1FY27 and up 25.95% YoY over Rs 53.34 in Q2FY26. For H1FY27, Standalone EPS before exceptional items was Rs 105.94, a growth of 13.66% YoY against Rs 93.21 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> </ul> <p><strong>Milind Thatte, Managing Director, P&G Health India, said:</strong> “We have delivered another strong quarter with double-digit topline and bottom-line growth, continuing the momentum of the previous quarters. The growth reflects the positive response of consumers, patients and health care professionals (HCPs) to our science-backed superior healthcare products and innovations amid growing consumer focus on preventive health. It also demonstrates the impact of our strong retail execution, new consumer communication and HCP awareness initiatives and strengthened go-to-market and supply chain capabilities.</p> <p>We are delivering balanced growth and value creation for all our stakeholders, driven by our strategy that is centred on a focused portfolio of quality, trusted and highly recommended brands where performance drives brand choice, superiority (across product, package, brand communication, retail execution and value), constructive disruption, productivity, and an agile accountable organization.”</p> <p><a class="lb" href="/get-document/post/pdf/5923292/" target="_blank">Result PDF</a></p>

Procter & Gamble Health Ltd - 500126 - Press Release

Press release for the unaudited financial results for the quarter ended September 30, 2026.

Procter & Gamble Health Financials

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹5,543.50
-52 (-0.93%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹5,590.50
  • 50 Day
  • ₹5,572.70
  • 100 Day
  • ₹5,653.60
  • 200 Day
  • ₹5,679.60

Resistance and Support

5565.67 Pivot Speed
  • R3 5,992.00
  • R2 5,906.50
  • R1 5,751.00
  • S1 5,510.00
  • S2 5,424.50
  • S3 5,269.00

Procter & Gamble Health Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-02 Quarterly Results
2026-08-06 Quarterly Results
2026-05-26 Audited Results & Final Dividend
2026-02-06 Quarterly Results & Interim Dividend
2025-11-05 Quarterly Results & Interim Dividend
Date Purpose Remarks
2026-08-27 FINAL Rs.45.00 per share(450%)Final Dividend (RD & XD dates revised)
2026-02-12 SPECIAL Rs.50.00 per share(500%)Special Dividend
2026-02-12 INTERIM Rs.110.00 per share(1100%)Interim Dividend
2025-08-22 FINAL Rs.45.00 per share(450%)Final Dividend
2025-02-21 INTERIM Rs.80.00 per share(800%)Interim Dividend
View Procter & Gamble Health Dividend History Arrow

Procter & Gamble Health Shareholding Pattern

51.82%
29.13%
8.89%
6.43%
3.74%

Procter & Gamble Health FAQs

Procter & Gamble Health share price is ₹5,543 As on 17 November, 2026 | 09:18

The Market Cap of Procter & Gamble Health is ₹9201.9 Cr As on 17 November, 2026 | 09:18

The P/E ratio of Procter & Gamble Health is 24.2 As on 17 November, 2026 | 09:18

The PB ratio of Procter & Gamble Health is 14.8 As on 17 November, 2026 | 09:18

The 52 week High & Low of Procter & Gamble Health is ₹6975/₹4707 respectively As on 17 November, 2026 | 09:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23